Peter Knapp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter Knapp has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
- Peter Bower
The University of Manchester
10 shared publications Rebecca Sheridan
Department of Health Sciences, University of York, York, UK
8 shared publications- Jacqueline Martin-Kerry
School of Health Sciences, University of East Anglia, Norwich, UK
7 shared publications - Rebecca Sheridan
York Trials Unit, Department of Health Sciences, University of York, York, UK
6 shared publications - David J. Torgerson
York Trials Unit, University of York, York, UK
5 shared publications David K. Raynor
School of Healthcare, University of Leeds, Leeds, UK
5 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Springer Nature in BMC Health Services Research
How do doctors discuss dementia treatments with patients? Content analysis of the presentation of treatment information, benefits and side effects
Background: The benefits and side effects of pharmacological treatments for dementia are inherently difficult to qualify. Little is known about how treatments are discussed in practice, despite the impact of discissions on the decision to take treatments, understanding of medications, and adherence. This study sought to understand how the benefits and side effects of treatments are communicated in clinical encounters. Methods: Twenty-nine memory assessment clinic consultations across two UK NHS Trusts were video recorded, involving ten clinicians, 29 patients and 32 relatives or supporters. Consultations were analysed using content analysis to identify patterns in communication. Results: Findings indicted that whilst there were some common approaches to presenting treatments, discussions varied in ways that could influence patient outcomes. In 26 of the 29 consultations benefits of treatments were presented as symptom management, most commonly with a focus on memory and cognition. In 13 of the 29 consultations clinicians specified that treatment was not curative. One third of consultations, at some point, suggested treatments may be disease modifying, and around half referred to symptom reduction or delay. Side effects were discussed in 26 of 29 consultations, often with verbal qualifiers indicating the certainty or likelihood of the effects. The side effect profile was commonly described as not serious/minimising . How treatments worked was described in 13 consultations, with eight presenting this in a patient friendly way. Discussions of risk/benefit occurred in half of the consultations. Conclusions: Our analysis showed positive framing of the benefits of dementia treatments by clinicians. There was a lack of consistency in the way that both benefits and side effects were described. Recommendations include guidance for discussing dementia medications to promote understanding and informed decision making including (1) caution about using leading language (2) ensuring consistent and transparent communication and (3) employing evidence-based patient decision aids where appropriate. Clinical trial number: Not applicable.
- 6 October 2026
- Published by Springer Nature in BMC Health Services Research
Open AccessHow do doctors discuss dementia treatments with patients? Content analysis of the presentation of treatment information, benefits and side effects
Background: The benefits and side effects of pharmacological treatments for dementia are inherently difficult to qualify. Little is known about how treatments are discussed in practice, despite the impact of discissions on the decision to take treatments, understanding of medications, and adherence. This study sought to understand how the benefits and side effects of treatments are communicated in clinical encounters. Methods: Twenty-nine memory assessment clinic consultations across two UK NHS Trusts were video recorded, involving ten clinicians, 29 patients and 32 relatives or supporters. Consultations were analysed using content analysis to identify patterns in communication. Results: Findings indicted that whilst there were some common approaches to presenting treatments, discussions varied in ways that could influence patient outcomes. In 26 of the 29 consultations benefits of treatments were presented as symptom management, most commonly with a focus on memory and cognition. In 13 of the 29 consultations clinicians specified that treatment was not curative. One third of consultations, at some point, suggested treatments may be disease modifying, and around half referred to symptom reduction or delay. Side effects were discussed in 26 of 29 consultations, often with verbal qualifiers indicating the certainty or likelihood of the effects. The side effect profile was commonly described as not serious/minimising . How treatments worked was described in 13 consultations, with eight presenting this in a patient friendly way. Discussions of risk/benefit occurred in half of the consultations. Conclusions: Our analysis showed positive framing of the benefits of dementia treatments by clinicians. There was a lack of consistency in the way that both benefits and side effects were described. Recommendations include guidance for discussing dementia medications to promote understanding and informed decision making including (1) caution about using leading language (2) ensuring consistent and transparent communication and (3) employing evidence-based patient decision aids where appropriate. Clinical trial number: Not applicable.
- Open Access
- 11 June 2026
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 13
The Readability of British Association of Urology Society Patient Information Leaflets: Have We Done Enough for Patients to Understand?
Introduction: Patient Information leaflets (PILs) from the British Association of Urologists (BAUS) are commonly used to communicate to patients about surgical procedures, but previous studies have highlighted that they are too difficult for some patients to read. BAUS PILs have since been rewritten using guidelines which emphasize readability. Objectives: To identify if the readability of BAUS PILs has changed compared to historical versions. Methods: Current BAUS PILs (published 2020-2025) were compared with historical PILs with similar titles from 2014 to 2016 using a custom Python script. Results: Readability scores improved by a significant ( P < .001) albeit small amount (FKGL 8.83 vs 8.67; SMOG 11.86 vs 11.71; FRE 57.06 vs 57.47), and continue to have a suboptimal readability. The revised PILs had significantly fewer long sentences (10.11% vs 6.84% P < .0001), fewer sentences that used the “passive voice” (30.50% vs 16.22% P < .0001) and were shorter (1875.5 words vs 1726 P = .004). Conclusion: While there have been small improvements in urology PILs for patients, they remain too difficult for many patients, and more work is needed to improve readability.
- 11 June 2026
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 13
Open AccessThe Readability of British Association of Urology Society Patient Information Leaflets: Have We Done Enough for Patients to Understand?
Introduction: Patient Information leaflets (PILs) from the British Association of Urologists (BAUS) are commonly used to communicate to patients about surgical procedures, but previous studies have highlighted that they are too difficult for some patients to read. BAUS PILs have since been rewritten using guidelines which emphasize readability. Objectives: To identify if the readability of BAUS PILs has changed compared to historical versions. Methods: Current BAUS PILs (published 2020-2025) were compared with historical PILs with similar titles from 2014 to 2016 using a custom Python script. Results: Readability scores improved by a significant ( P < .001) albeit small amount (FKGL 8.83 vs 8.67; SMOG 11.86 vs 11.71; FRE 57.06 vs 57.47), and continue to have a suboptimal readability. The revised PILs had significantly fewer long sentences (10.11% vs 6.84% P < .0001), fewer sentences that used the “passive voice” (30.50% vs 16.22% P < .0001) and were shorter (1875.5 words vs 1726 P = .004). Conclusion: While there have been small improvements in urology PILs for patients, they remain too difficult for many patients, and more work is needed to improve readability.
- Open Access
- 5 September 2025
- Published by Wiley in Journal of Advanced Nursing
- Vol. 82 (5) , 5521-5533
Developing an Intervention to Improve Sexual Health Assessment and Care in Men With Inflammatory Bowel Disease
Aim: To co‐produce a prototype intervention to help nurses improve the assessment and care of the sexual health needs of men with inflammatory bowel disease. Background: Inflammatory bowel disease can have a significant impact on the sexual health and well‐being of men, but has largely been neglected in research and clinical guidelines. Men with the disease report that sexual health is not discussed during consultations, while healthcare practitioners describe a lack of confidence to initiate sexual health assessments. At present, no evidence‐based tool exists to support nurses in detecting, assessing, and providing care for the sexual health of men with the disease. Design: A mixed‐methods study shaped by phase 1 of the Medical Research Council's framework for the development of complex interventions. Methods: (1) Cross‐sectional surveys of (i) men with inflammatory bowel disease, (ii) nurses, and (iii) inflammatory bowel disease services to determine the current state of sexual health provision across the UK National Health Service. (2) Semi‐structured interviews with men and the partners of men with IBD and asynchronous focus groups with health professionals to explore appropriate and acceptable ways to provide sexual healthcare. (3) Three consecutive co‐production workshops inclusive of men with the disease, healthcare professionals, and stakeholders to formulate a prototype intervention. Implications for the Profession and/or Patient Care: This study will create an evidence‐based prototype intervention that will provide nurses with the knowledge and skills required to effectively assess the sexual health needs of men with inflammatory bowel disease and provide appropriate, patient‐centred care. Patient Contribution: The study design was supported by a patient group. The study delivery will be supported by a patient co‐investigator and stakeholder group inclusive of men with lived experience of the disease. Reporting Method: This report adheres to the SPIRIT 2013 checklist for standard protocol items for clinical trials. Trial Registration: clinicaltrials.gov ID: NCT06562751
- 5 September 2025
- Published by Wiley in Journal of Advanced Nursing
- Vol. 82 (5) , 5521-5533
Open AccessDeveloping an Intervention to Improve Sexual Health Assessment and Care in Men With Inflammatory Bowel Disease
Aim: To co‐produce a prototype intervention to help nurses improve the assessment and care of the sexual health needs of men with inflammatory bowel disease. Background: Inflammatory bowel disease can have a significant impact on the sexual health and well‐being of men, but has largely been neglected in research and clinical guidelines. Men with the disease report that sexual health is not discussed during consultations, while healthcare practitioners describe a lack of confidence to initiate sexual health assessments. At present, no evidence‐based tool exists to support nurses in detecting, assessing, and providing care for the sexual health of men with the disease. Design: A mixed‐methods study shaped by phase 1 of the Medical Research Council's framework for the development of complex interventions. Methods: (1) Cross‐sectional surveys of (i) men with inflammatory bowel disease, (ii) nurses, and (iii) inflammatory bowel disease services to determine the current state of sexual health provision across the UK National Health Service. (2) Semi‐structured interviews with men and the partners of men with IBD and asynchronous focus groups with health professionals to explore appropriate and acceptable ways to provide sexual healthcare. (3) Three consecutive co‐production workshops inclusive of men with the disease, healthcare professionals, and stakeholders to formulate a prototype intervention. Implications for the Profession and/or Patient Care: This study will create an evidence‐based prototype intervention that will provide nurses with the knowledge and skills required to effectively assess the sexual health needs of men with inflammatory bowel disease and provide appropriate, patient‐centred care. Patient Contribution: The study design was supported by a patient group. The study delivery will be supported by a patient co‐investigator and stakeholder group inclusive of men with lived experience of the disease. Reporting Method: This report adheres to the SPIRIT 2013 checklist for standard protocol items for clinical trials. Trial Registration: clinicaltrials.gov ID: NCT06562751
- Open Access
- 2 August 2025
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 39 (2) , 145-160
Influential Factors when Making Decisions About Dementia Medications in Memory Assessment Services; a Focused Ethnography and Interview Study
Background: Discussing pharmaceutical treatment for dementia is challenging because of variation in disease progression, lack of curative treatments, and communication difficulties. Research in the context of dementia suggests shared decision making is limited, this study examined how dementia medications are discussed in practice. Methods: Focused video/audio ethnography of clinical appointments (n = 14), semi-structured interviews with patients/supporters (n = 23) and clinicians (n = 5) were employed to examine communication practices. Results: Two themes developed; Framing and understanding of information in the context of uncertainty explores how uncertainties around risks and benefits are understood. ‘Not worth the risk’ or ‘ nothing to lose ’ presents how patients/supporters and clinicians balance individuals’ contexts/perceived risks/benefits. In the absence of certainty around potential benefits, risk often informed decision-making, particularly for frailer or more vulnerable patients. Conclusions: Clinicians should be aware of their influence on decision-making and be cognisant of the way that they frame opinions, which are largely based on clinical experience. Prescribers would benefit from a standardised information source which enables them to describe the likelihood and magnitude of benefits and side effects in a universal way. Accessible information for patients and relatives about the same is also recommended. Patients and relatives make their decisions to take medications in the context of relative uncertainty about the likelihood of benefits, with risk playing a pivotal role in decision making for some.
- 2 August 2025
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 39 (2) , 145-160
Open AccessInfluential Factors when Making Decisions About Dementia Medications in Memory Assessment Services; a Focused Ethnography and Interview Study
Background: Discussing pharmaceutical treatment for dementia is challenging because of variation in disease progression, lack of curative treatments, and communication difficulties. Research in the context of dementia suggests shared decision making is limited, this study examined how dementia medications are discussed in practice. Methods: Focused video/audio ethnography of clinical appointments (n = 14), semi-structured interviews with patients/supporters (n = 23) and clinicians (n = 5) were employed to examine communication practices. Results: Two themes developed; Framing and understanding of information in the context of uncertainty explores how uncertainties around risks and benefits are understood. ‘Not worth the risk’ or ‘ nothing to lose ’ presents how patients/supporters and clinicians balance individuals’ contexts/perceived risks/benefits. In the absence of certainty around potential benefits, risk often informed decision-making, particularly for frailer or more vulnerable patients. Conclusions: Clinicians should be aware of their influence on decision-making and be cognisant of the way that they frame opinions, which are largely based on clinical experience. Prescribers would benefit from a standardised information source which enables them to describe the likelihood and magnitude of benefits and side effects in a universal way. Accessible information for patients and relatives about the same is also recommended. Patients and relatives make their decisions to take medications in the context of relative uncertainty about the likelihood of benefits, with risk playing a pivotal role in decision making for some.
- Open Access
- 1 August 2025
- Published by National Institute for Health and Care Research in Health Technology Assessment
- p. 1-49
OrthoticS for TReatment of symptomatic flat feet In CHildren (OSTRICH): a randomised controlled trial
Background: Children and young people with symptomatic pes planus (flat feet) often seek treatment from healthcare professionals. There are various treatment options, but there is a lack of high-quality evidence about which is most effective. Objectives: To assess the clinical and cost-effectiveness of prefabricated orthoses, plus exercise and advice, compared with exercise and advice alone on physical function, measured using the physical domain of the Oxford Ankle Foot Questionnaire for Children, among children with symptomatic pes planus. Design and methods: A pragmatic, multicentre, two-armed individually randomised controlled trial with an internal pilot, economic evaluation and qualitative study. Setting and participants: Children and young people aged 6–14 years with symptomatic flat feet were recruited from hospital or community healthcare facilities in England and Wales. Participants were randomised 1 : 1 using a secure web-based randomisation system and followed up for up to 12 months. Interventions: We planned to provide all participants with advice and exercises, with the intervention group also receiving a prefabricated orthosis. Due to the nature of the study treatments, blinding of participants or the research team was not possible. Main outcome measures: The primary outcome was the physical domain subscale of the Oxford Ankle Foot Questionnaire for Children over the 12-month follow-up. Secondary outcomes included the physical domain subscale at 3, 6 and 12 months, and the ‘School and Play’ and ‘Emotional’ domains of the Oxford Ankle Foot Questionnaire, pain scores, healthcare resource use, EQ-5D-Y and Child Health Utility 9D at all time points. The qualitative study drew on health literacy and health belief perspectives and examined fidelity and explored the experiences of being in the trial for those receiving and delivering the study treatments. Results: COVID-19 severely delayed trial set-up and recruitment and the study closed before meeting its recruitment target. Of 549 participants assessed for eligibility, 134 were randomised (intervention n = 70, control n = 64). The mean age of participants was 10.6 years (range 6.3–14.8) and 55.2% were male. No adverse events were reported. The planned statistical and health economic analyses could not be fully conducted due to the limited data. The qualitative study identified pain, posture and gait as the most common concerns by participants with pain relief as the primary motivator for seeking health care. Participants generally reported little understanding of their condition with barriers including misattribution (e.g. growing pains). Misinformation was common emphasising a need for accessible accurate education materials and structured follow-up care. There was a common belief that orthoses were superior to exercises leading to high levels of adherence, satisfaction and outcomes with orthoses compared with poor adherence, and low perceived efficacy with exercises linked to challenges incorporating these into daily routines. Limitations: We could not deliver the study objectives as planned. Due to the limited data available, we were unable to undertake the planned analysis. Conclusions: The COVID-19 pandemic significantly impacted trial set-up and recruitment. Extending the study was not feasible due to cost and time constraints. Future work: The evidence for the clinical and cost-effectiveness of orthotics for the treatment of symptomatic flat feet in children remains inconclusive and an area for further research. Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR127510.
- 1 August 2025
- Published by National Institute for Health and Care Research in Health Technology Assessment
- p. 1-49
Open AccessOrthoticS for TReatment of symptomatic flat feet In CHildren (OSTRICH): a randomised controlled trial
Background: Children and young people with symptomatic pes planus (flat feet) often seek treatment from healthcare professionals. There are various treatment options, but there is a lack of high-quality evidence about which is most effective. Objectives: To assess the clinical and cost-effectiveness of prefabricated orthoses, plus exercise and advice, compared with exercise and advice alone on physical function, measured using the physical domain of the Oxford Ankle Foot Questionnaire for Children, among children with symptomatic pes planus. Design and methods: A pragmatic, multicentre, two-armed individually randomised controlled trial with an internal pilot, economic evaluation and qualitative study. Setting and participants: Children and young people aged 6–14 years with symptomatic flat feet were recruited from hospital or community healthcare facilities in England and Wales. Participants were randomised 1 : 1 using a secure web-based randomisation system and followed up for up to 12 months. Interventions: We planned to provide all participants with advice and exercises, with the intervention group also receiving a prefabricated orthosis. Due to the nature of the study treatments, blinding of participants or the research team was not possible. Main outcome measures: The primary outcome was the physical domain subscale of the Oxford Ankle Foot Questionnaire for Children over the 12-month follow-up. Secondary outcomes included the physical domain subscale at 3, 6 and 12 months, and the ‘School and Play’ and ‘Emotional’ domains of the Oxford Ankle Foot Questionnaire, pain scores, healthcare resource use, EQ-5D-Y and Child Health Utility 9D at all time points. The qualitative study drew on health literacy and health belief perspectives and examined fidelity and explored the experiences of being in the trial for those receiving and delivering the study treatments. Results: COVID-19 severely delayed trial set-up and recruitment and the study closed before meeting its recruitment target. Of 549 participants assessed for eligibility, 134 were randomised (intervention n = 70, control n = 64). The mean age of participants was 10.6 years (range 6.3–14.8) and 55.2% were male. No adverse events were reported. The planned statistical and health economic analyses could not be fully conducted due to the limited data. The qualitative study identified pain, posture and gait as the most common concerns by participants with pain relief as the primary motivator for seeking health care. Participants generally reported little understanding of their condition with barriers including misattribution (e.g. growing pains). Misinformation was common emphasising a need for accessible accurate education materials and structured follow-up care. There was a common belief that orthoses were superior to exercises leading to high levels of adherence, satisfaction and outcomes with orthoses compared with poor adherence, and low perceived efficacy with exercises linked to challenges incorporating these into daily routines. Limitations: We could not deliver the study objectives as planned. Due to the limited data available, we were unable to undertake the planned analysis. Conclusions: The COVID-19 pandemic significantly impacted trial set-up and recruitment. Extending the study was not feasible due to cost and time constraints. Future work: The evidence for the clinical and cost-effectiveness of orthotics for the treatment of symptomatic flat feet in children remains inconclusive and an area for further research. Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR127510.
- Open Access
- 8 June 2025
- Published by Wiley in Health Expectations
- Vol. 28 (3) , e70321
Can a Public and Patient Involvement (PPI) Informed Participant Information Leaflet (PIL) Improve Trial Recruitment, Retention, and Quality of Decision Making? Results of a Randomised Controlled Double‐Blind Study Within a Trial (SWAT)
Introduction: Public and patient involvement (PPI) may be utilised to improve aspects of trial conduct. This study within a trial (SWAT) aimed to examine if a PPI‐informed participant information leaflet (PIL) could improve recruitment, retention, and quality of decision‐making of an exercise‐based rehabilitation trial (RESTORE II) for upper gastrointestinal (UGI) cancer survivors. Methods: This SWAT was conducted over two phases. Phase 1 applied qualitative methods to develop and refine a PPI‐informed PIL. Phase 2 embedded a randomised controlled double‐blind SWAT within the RESTORE II trial, comparing a standard PIL (PIL A) to the PPI‐informed PIL (PIL B) in terms of recruitment, retention, and quality of decision‐making (Decision Making Questionnaire [DMQ]). Results: Phase 1 recruited 16 PPI members (mean age 67.01 [9.28] years, mostly male [81.25%] and all UGI cancer survivors). Participants reviewed the standard PIL A and made suggestions for improvement, including revisions to the layout, title, text, provision of key information on the first page, and greater emphasis on the potential benefits of participation. This feedback was used to draft the alternative PIL B, which the Phase 1 participants reviewed and refined through minor changes to the appearance, text, and layout. In Phase 2, 307 potential RESTORE II trial participants were randomised to receive either PIL A ( n = 154) or PIL B ( n = 153). The overall recruitment rate was 28.7%. (PIL A 26.6% vs. PIL B 30.7%, OR 1.22 [95% CI 0.74 to 2.01, p = 0.43]), retention was 84.1% (PIL A 85.4% vs. PIL B 83.0%, OR 0.84 [95% CI 0.26 to 2.65, p = 0.760]). No significant difference in mean (SD) DMQ scores was observed: PIL A: 29.1 (4.4) vs. PIL B: 29.1 (5.1) (mean difference 0.03, 95% CI −1.64 to 1.69, p = 0.49). Conclusions: A PPI‐informed PIL did not improve recruitment, retention, or decision‐making for the RESTORE II trial. Patient or Public Contribution: Patients with UGI cancer informed the development of the interventional PIL B. Author P.B. provided input from the patient's perspective throughout the SWAT as a member of the Trial Steering Committee, providing oversight to the SWAT management, and contributed to analysis and the production of this manuscript. Trial Registration: SWAT Registration: The Northern Ireland Hub for Trials Methodology Research, SWAT Store, SWAT 100 https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,914713,en.pdf . Host Trial Registration Clinical Trials. gov https://clinicaltrials.gov/study/NCT03958019 .
- 8 June 2025
- Published by Wiley in Health Expectations
- Vol. 28 (3) , e70321
Open AccessCan a Public and Patient Involvement (PPI) Informed Participant Information Leaflet (PIL) Improve Trial Recruitment, Retention, and Quality of Decision Making? Results of a Randomised Controlled Double‐Blind Study Within a Trial (SWAT)
Introduction: Public and patient involvement (PPI) may be utilised to improve aspects of trial conduct. This study within a trial (SWAT) aimed to examine if a PPI‐informed participant information leaflet (PIL) could improve recruitment, retention, and quality of decision‐making of an exercise‐based rehabilitation trial (RESTORE II) for upper gastrointestinal (UGI) cancer survivors. Methods: This SWAT was conducted over two phases. Phase 1 applied qualitative methods to develop and refine a PPI‐informed PIL. Phase 2 embedded a randomised controlled double‐blind SWAT within the RESTORE II trial, comparing a standard PIL (PIL A) to the PPI‐informed PIL (PIL B) in terms of recruitment, retention, and quality of decision‐making (Decision Making Questionnaire [DMQ]). Results: Phase 1 recruited 16 PPI members (mean age 67.01 [9.28] years, mostly male [81.25%] and all UGI cancer survivors). Participants reviewed the standard PIL A and made suggestions for improvement, including revisions to the layout, title, text, provision of key information on the first page, and greater emphasis on the potential benefits of participation. This feedback was used to draft the alternative PIL B, which the Phase 1 participants reviewed and refined through minor changes to the appearance, text, and layout. In Phase 2, 307 potential RESTORE II trial participants were randomised to receive either PIL A ( n = 154) or PIL B ( n = 153). The overall recruitment rate was 28.7%. (PIL A 26.6% vs. PIL B 30.7%, OR 1.22 [95% CI 0.74 to 2.01, p = 0.43]), retention was 84.1% (PIL A 85.4% vs. PIL B 83.0%, OR 0.84 [95% CI 0.26 to 2.65, p = 0.760]). No significant difference in mean (SD) DMQ scores was observed: PIL A: 29.1 (4.4) vs. PIL B: 29.1 (5.1) (mean difference 0.03, 95% CI −1.64 to 1.69, p = 0.49). Conclusions: A PPI‐informed PIL did not improve recruitment, retention, or decision‐making for the RESTORE II trial. Patient or Public Contribution: Patients with UGI cancer informed the development of the interventional PIL B. Author P.B. provided input from the patient's perspective throughout the SWAT as a member of the Trial Steering Committee, providing oversight to the SWAT management, and contributed to analysis and the production of this manuscript. Trial Registration: SWAT Registration: The Northern Ireland Hub for Trials Methodology Research, SWAT Store, SWAT 100 https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/Filetoupload,914713,en.pdf . Host Trial Registration Clinical Trials. gov https://clinicaltrials.gov/study/NCT03958019 .
- Open Access
- 27 May 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 1-13
Why do patients take part in research? An updated overview of systematic reviews of psychosocial barriers and facilitators
Background: Efficient, equitable health research depends on understanding why people decide to take part. The aims of this overview were to update the version published in 2020, identifying psychosocial influences on participation and mapping them to recruitment research and psychological theory. Methods: Searches were undertaken in February 2024. Qualitative, quantitative, and mixed-methods systematic reviews were identified, without language or date limits. Methodological quality was rated using AMSTAR-2, and low-quality reviews were excluded. Barriers and facilitators were identified inductively and mapped to the Theoretical Domains Framework (TDF) and COM-B model, and to empirical recruitment research. Results: The update included 70 reviews, including 44 new reviews, covering a breadth of populations and settings, and drawing on 1940 primary studies (1428 unique). We identified 15 facilitators, most commonly: altruism, potential for personal benefit and trust. Incentives and convenient, low-burden research were also facilitators. Another 10 facilitators were new to this update. There were 16 barriers, most commonly: perceived risk, practical difficulties, and distrust of researchers. Many barriers applied to specific designs, particularly randomised trials. Factors that were barriers or facilitators include the influence of others and information quality. Barriers and facilitators were coded to the Motivation and Opportunity components of the TDF, particularly knowledge and social influences; only two factors were coded to a Capability. Psychosocial influences and empirical recruitment research had some overlap, but some barriers and facilitators had not been evaluated. Conclusions: Common barriers and facilitators to research participation were identified, some new to this update, which could be addressed through targeted recruitment strategies to increase the efficiency and generalisability of primary research. Factors affecting participation are not only personal; they are also normative and social. The priorities are to change the ways we recruit to research (perhaps tested in SWATs) and identify barriers and facilitators in areas not well covered in current research. Trial registration: PROSPERO CRD42017062738. Registered on April 2017.
- 27 May 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 1-13
Open AccessWhy do patients take part in research? An updated overview of systematic reviews of psychosocial barriers and facilitators
Background: Efficient, equitable health research depends on understanding why people decide to take part. The aims of this overview were to update the version published in 2020, identifying psychosocial influences on participation and mapping them to recruitment research and psychological theory. Methods: Searches were undertaken in February 2024. Qualitative, quantitative, and mixed-methods systematic reviews were identified, without language or date limits. Methodological quality was rated using AMSTAR-2, and low-quality reviews were excluded. Barriers and facilitators were identified inductively and mapped to the Theoretical Domains Framework (TDF) and COM-B model, and to empirical recruitment research. Results: The update included 70 reviews, including 44 new reviews, covering a breadth of populations and settings, and drawing on 1940 primary studies (1428 unique). We identified 15 facilitators, most commonly: altruism, potential for personal benefit and trust. Incentives and convenient, low-burden research were also facilitators. Another 10 facilitators were new to this update. There were 16 barriers, most commonly: perceived risk, practical difficulties, and distrust of researchers. Many barriers applied to specific designs, particularly randomised trials. Factors that were barriers or facilitators include the influence of others and information quality. Barriers and facilitators were coded to the Motivation and Opportunity components of the TDF, particularly knowledge and social influences; only two factors were coded to a Capability. Psychosocial influences and empirical recruitment research had some overlap, but some barriers and facilitators had not been evaluated. Conclusions: Common barriers and facilitators to research participation were identified, some new to this update, which could be addressed through targeted recruitment strategies to increase the efficiency and generalisability of primary research. Factors affecting participation are not only personal; they are also normative and social. The priorities are to change the ways we recruit to research (perhaps tested in SWATs) and identify barriers and facilitators in areas not well covered in current research. Trial registration: PROSPERO CRD42017062738. Registered on April 2017.
- Open Access
- 1 November 2023
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 11 (24) , 1-112
The effectiveness and acceptability of multimedia information when recruiting children and young people to trials: the TRECA meta-analysis of SWATs
Background: The information provided to potential trial participants plays a crucial role in their decision-making. Printed participant information sheets for trials have received recurrent criticism as being too long and technical, unappealing and hard to navigate. An alternative is to provide information through multimedia (text, animations, video, audio, diagrams and photos). However, there is limited evidence on the effects of multimedia participant information on research recruitment rates, particularly in children and young people. Objectives: The study objectives were as follows: to develop template multimedia information resources through participatory design, for use when recruiting children and young people to trials to evaluate the multimedia information resources in a series of Studies Within A Trial, to test their effects on recruitment and retention rates, and participant decision-making, by comparing the provision of multimedia information resources instead of printed participant information sheets, and comparing the provision of multimedia information resources in addition to printed participant information sheets. Design: Two-phase study: multimedia information resources development including qualitative study; user testing study; readability metrics; enhanced patient and public involvement multimedia information resources’ evaluation comprising Studies Within A Trial undertaken within host trials recruiting children and young people. Setting: United Kingdom trials involving patients aged under 18. Participants: Development phase: n = 120 (children and young people, parents, clinicians, trial personnel). Evaluation phase: n = 1906 (children and young people being asked to take part in trials). Interventions: Multimedia information resources (comprising text, audio, ‘talking heads’ video, trial-specific and trial-generic animations). Printed participant information sheets. Main outcome measures: Primary outcome: trial recruitment rate comparing multimedia information resource-only with printed participant information sheet-only provision. Secondary outcomes: trial recruitment rate comparing combined multimedia information resource and printed participant information sheet with printed participant information sheet-only provision; trial retention rate; quality of participant decision-making. Results for each trial were calculated and combined in a two-stage random-effects meta-analysis. Results: Phase 1 generated two multimedia information resource templates: (1) for children aged 6–11 years; (2) for children aged 12–18 years and parents. In the Phase 2 Studies Within A Trial the multimedia information resources improved trial recruitment, when compared to printed information alone [odds ratio (OR) = 1.54; 95% confidence interval (CI) 1.05 to 2.28; p = 0.03; I2 = 0%]. When printed participant information sheet-only provision was compared to combined multimedia information resource and printed participant information sheet provision, there was no effect on trial recruitment (OR = 0.89; 95% CI 0.53 to 1.50; I2 = 0%). There were no differences between multimedia information resource and printed participant information sheet on trial retention or participant decision-making quality. In a study within a hypothetical trial setting, multimedia information resource-only provision produced higher ratings of ‘information was easy to understand’ (Z = 3.03; p = 0.003) and ‘I had confidence in decision-making’ (Z = 2.00; p = 0.044) than printed participant information sheet-only provision. Limitations: It was not possible to include data from three Studies Within A Trial in the meta-analysis due to limited sample size, and questionnaire return rates were low, which reduced the strength of the findings. Conclusions: Use of multimedia information increased the rate of recruitment to trials involving children and young people compared to standard patient information sheets. Future work: There should be further evaluation of the effects of multimedia information on recruitment to trials involving children and young people. It would be valuable to assess any impacts of multimedia information resources on communication between trial recruiters, children and young people, and parents. Study registration: This trial is registered as TRECA ISRCTN 73136092 and Northern Ireland Hub for Trials Methodology Research SWAT Repository (SWAT 97). Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: 14/21/21) and is published in full in Health and Social Care Delivery Research; Vol. 11, No. 24. See the NIHR Funding and Awards website for further award information.
- 1 November 2023
- Published by National Institute for Health and Care Research in Health and Social Care Delivery Research
- Vol. 11 (24) , 1-112
Open AccessThe effectiveness and acceptability of multimedia information when recruiting children and young people to trials: the TRECA meta-analysis of SWATs
Background: The information provided to potential trial participants plays a crucial role in their decision-making. Printed participant information sheets for trials have received recurrent criticism as being too long and technical, unappealing and hard to navigate. An alternative is to provide information through multimedia (text, animations, video, audio, diagrams and photos). However, there is limited evidence on the effects of multimedia participant information on research recruitment rates, particularly in children and young people. Objectives: The study objectives were as follows: to develop template multimedia information resources through participatory design, for use when recruiting children and young people to trials to evaluate the multimedia information resources in a series of Studies Within A Trial, to test their effects on recruitment and retention rates, and participant decision-making, by comparing the provision of multimedia information resources instead of printed participant information sheets, and comparing the provision of multimedia information resources in addition to printed participant information sheets. Design: Two-phase study: multimedia information resources development including qualitative study; user testing study; readability metrics; enhanced patient and public involvement multimedia information resources’ evaluation comprising Studies Within A Trial undertaken within host trials recruiting children and young people. Setting: United Kingdom trials involving patients aged under 18. Participants: Development phase: n = 120 (children and young people, parents, clinicians, trial personnel). Evaluation phase: n = 1906 (children and young people being asked to take part in trials). Interventions: Multimedia information resources (comprising text, audio, ‘talking heads’ video, trial-specific and trial-generic animations). Printed participant information sheets. Main outcome measures: Primary outcome: trial recruitment rate comparing multimedia information resource-only with printed participant information sheet-only provision. Secondary outcomes: trial recruitment rate comparing combined multimedia information resource and printed participant information sheet with printed participant information sheet-only provision; trial retention rate; quality of participant decision-making. Results for each trial were calculated and combined in a two-stage random-effects meta-analysis. Results: Phase 1 generated two multimedia information resource templates: (1) for children aged 6–11 years; (2) for children aged 12–18 years and parents. In the Phase 2 Studies Within A Trial the multimedia information resources improved trial recruitment, when compared to printed information alone [odds ratio (OR) = 1.54; 95% confidence interval (CI) 1.05 to 2.28; p = 0.03; I2 = 0%]. When printed participant information sheet-only provision was compared to combined multimedia information resource and printed participant information sheet provision, there was no effect on trial recruitment (OR = 0.89; 95% CI 0.53 to 1.50; I2 = 0%). There were no differences between multimedia information resource and printed participant information sheet on trial retention or participant decision-making quality. In a study within a hypothetical trial setting, multimedia information resource-only provision produced higher ratings of ‘information was easy to understand’ (Z = 3.03; p = 0.003) and ‘I had confidence in decision-making’ (Z = 2.00; p = 0.044) than printed participant information sheet-only provision. Limitations: It was not possible to include data from three Studies Within A Trial in the meta-analysis due to limited sample size, and questionnaire return rates were low, which reduced the strength of the findings. Conclusions: Use of multimedia information increased the rate of recruitment to trials involving children and young people compared to standard patient information sheets. Future work: There should be further evaluation of the effects of multimedia information on recruitment to trials involving children and young people. It would be valuable to assess any impacts of multimedia information resources on communication between trial recruiters, children and young people, and parents. Study registration: This trial is registered as TRECA ISRCTN 73136092 and Northern Ireland Hub for Trials Methodology Research SWAT Repository (SWAT 97). Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: 14/21/21) and is published in full in Health and Social Care Delivery Research; Vol. 11, No. 24. See the NIHR Funding and Awards website for further award information.
- Open Access
- 4 July 2023
- Published by Springer Nature in BMC Medicine
- Vol. 21 (1) , 1-16
Providing multimedia information to children and young people increases recruitment to trials: pre-planned meta-analysis of SWATs
Background: Randomised controlled trials are often beset by problems with poor recruitment and retention. Information to support decisions on trial participation is usually provided as printed participant information sheets (PIS), which are often long, technical, and unappealing. Multimedia information (MMI), including animations and videos, may be a valuable alternative or complement to a PIS. The Trials Engagement in Children and Adolescents (TRECA) study compared MMI to PIS to investigate the effects on participant recruitment, retention, and quality of decision-making.Methods: We undertook six SWATs (Study Within A Trial) within a series of host trials recruiting children and young people. Potential participants in the host trials were randomly allocated to receive MMI-only, PIS-only, or combined MMI + PIS. We recorded the rates of recruitment and retention (varying between 6 and 26 weeks post-randomisation) in each host trial. Potential participants approached about each host trial were asked to complete a nine-item Decision-Making Questionnaire (DMQ) to indicate their evaluation of the information and their reasons for participation/non-participation. Odds ratios were calculated and combined in a meta-analysis.Results: Data from 3/6 SWATs for which it was possible were combined in a meta-analysis (n = 1758). Potential participants allocated to MMI-only were more likely to be recruited to the host trial than those allocated to PIS-only (OR 1.54; 95% CI 1.05, 2.28;p = 0.03). Those allocated to combined MMI + PIS compared to PIS-only were no more likely to be recruited to the host trial (OR = 0.89; 95% CI 0.53, 1.50;p = 0.67). Providing MMI rather than PIS did not impact on DMQ scores. Once children and young people had been recruited to host trials, their trial retention rates did not differ according to intervention allocation.Conclusions: Providing MMI-only increased the trial recruitment rate compared to PIS-only but did not affect DMQ scores. Combined MMI + PIS instead of PIS had no effect on recruitment or retention. MMIs are a useful tool for trial recruitment in children and young people, and they could reduce trial recruitment periods.
- 4 July 2023
- Published by Springer Nature in BMC Medicine
- Vol. 21 (1) , 1-16
Open AccessProviding multimedia information to children and young people increases recruitment to trials: pre-planned meta-analysis of SWATs
Background: Randomised controlled trials are often beset by problems with poor recruitment and retention. Information to support decisions on trial participation is usually provided as printed participant information sheets (PIS), which are often long, technical, and unappealing. Multimedia information (MMI), including animations and videos, may be a valuable alternative or complement to a PIS. The Trials Engagement in Children and Adolescents (TRECA) study compared MMI to PIS to investigate the effects on participant recruitment, retention, and quality of decision-making.Methods: We undertook six SWATs (Study Within A Trial) within a series of host trials recruiting children and young people. Potential participants in the host trials were randomly allocated to receive MMI-only, PIS-only, or combined MMI + PIS. We recorded the rates of recruitment and retention (varying between 6 and 26 weeks post-randomisation) in each host trial. Potential participants approached about each host trial were asked to complete a nine-item Decision-Making Questionnaire (DMQ) to indicate their evaluation of the information and their reasons for participation/non-participation. Odds ratios were calculated and combined in a meta-analysis.Results: Data from 3/6 SWATs for which it was possible were combined in a meta-analysis (n = 1758). Potential participants allocated to MMI-only were more likely to be recruited to the host trial than those allocated to PIS-only (OR 1.54; 95% CI 1.05, 2.28;p = 0.03). Those allocated to combined MMI + PIS compared to PIS-only were no more likely to be recruited to the host trial (OR = 0.89; 95% CI 0.53, 1.50;p = 0.67). Providing MMI rather than PIS did not impact on DMQ scores. Once children and young people had been recruited to host trials, their trial retention rates did not differ according to intervention allocation.Conclusions: Providing MMI-only increased the trial recruitment rate compared to PIS-only but did not affect DMQ scores. Combined MMI + PIS instead of PIS had no effect on recruitment or retention. MMIs are a useful tool for trial recruitment in children and young people, and they could reduce trial recruitment periods.
- Open Access
- 20 June 2023
- Published by Elsevier in Patient Education and Counseling
- Vol. 114, 107861
Why do people take part in vaccine trials? A mixed methods narrative synthesis
- 20 June 2023
- Published by Elsevier in Patient Education and Counseling
- Vol. 114, 107861
Open AccessWhy do people take part in vaccine trials? A mixed methods narrative synthesis